Antiplatelet drugs and risk of venous thromboembolism: Results from the EDITH case-control study

Haematologica

Volumn 93, Issue 7, 2008, Pages 1117-1118

  Lacut, Karine ^a,b   Van Der Maaten, Jantien ^c   Le Gal, Grégoire ^a,b   Cornily, Géraldine ^a,b   Mottier, Dominique ^a,b   Oger, Emmanuel ^a,b  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antiplatelet drugs; Aspirin; Case control study; Thienopyridines; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; THIENOPYRIDINE DERIVATIVE;

AGED; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ASPIRIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PYRIDINES; REGRESSION ANALYSIS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 46849098803     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12331     Document Type: Letter

References (9)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994;308:235-46.
2. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) Trial. Lancet 2000;355:1295-302.
3. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-41.
4. Prandoni P, Ghiraduzzi A, Prins MH, Pergo V, Davidson BL, Sorensen H, et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006;4:1891-6.
5. Oger E, Lacut K, Le Gal G, Couturaud F, Guenet D, Abalain J-H, et al. Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. The EDITH Collaborative Study Group. J Thromb Haemost 2006;4:793-9.
6. Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med 2007;147:525-33.
7. Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2007;109:2285-92.
8. Szczeklik A, Krzanowski M, Gora P, Radwan J. Antiplatelet drugs and generation of thrombin in clotting. Blood 1992;80:2006-11.
9. Brighton TA, Eikelboom JW, Gallus A, Ockelford P, Becattini C, Agnelli G, et al. Low-dose aspirin for secondary prophylaxis of vein thrombosis - A prospectively planned meta-analysis. J Thromb Haemost 2005; 3 (Suppl 1):P2202[Abstract].